JNJ : Analysis & Opinions

  • Showing 201-204 of 204 items
  • <<
  • 1
  • 2
  • 3
  1. Bristol-Myers Hurt By Plavix, Saved By Demographics (BMY)

    November 16, 2006
    Despite BMY's recent struggles with its Plavix sales, favorable demographics make the stock a good investment to consider.
  2. Boston Scientific Shaken, But Not Stirred (BSX)

    November 8, 2006
    Boston Scientific looks poised for higher per share valuations in the future.
  3. Weakness At Target A Reason For Concern (TGT)

    July 18, 2006
    With an economic slowdown in the mix, Target may feel the pinch more than investors expect.
  4. Pfizer, Pass the Rolaids

    June 12, 2006
    $15 billion for its consumer products unit won’t cure Pfizer’s ailing stock.
  • Showing 201-204 of 204 items
  • <<
  • 1
  • 2
  • 3
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!